# Drug Intervention of Spontaneous Hyperventilation in Patients With Aneurysmal Subarachnoid Hemorrhage

> **NCT04940273** · NA · UNKNOWN · sponsor: **Capital Medical University** · enrollment: 30 (estimated)

## Conditions studied

- Hyperventilation
- Aneurysmal Subarachnoid Hemorrhage
- Cerebral Blood Flow

## Interventions

- **DRUG:** Remifentanil Injection [Ultiva]

## Key facts

- **NCT ID:** NCT04940273
- **Lead sponsor:** Capital Medical University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-06-01
- **Primary completion:** 2021-12-31
- **Final completion:** 2022-03-31
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2021-06-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04940273

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04940273, "Drug Intervention of Spontaneous Hyperventilation in Patients With Aneurysmal Subarachnoid Hemorrhage". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04940273. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*